Long-term survival of stage IV melanoma patients treated with a polyvalent, shed antigen, melanoma vaccine

被引：0
|
作者：
Laky, D
Shapiro, RL
Harris, MN
Roses, DF
Jacquotte, AZ
Reynolds, SR
Bystryn, J
机构：
[1] NYU, Sch Med, Kaplan Comprehens Canc Ctr, New York, NY USA
[2] NYU, Sch Med, Dept Surg, New York, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2002年 / 119卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
198
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [41] Long-term survival of real-world advanced melanoma patients treated with targeted therapy
    Ismail, R.
    de Boer, A.
    van Dartel, M.
    Hilarius, D.
    van Zeijl, M.
    van den Eertwegh, F.
    Aarts, M.
    Van den Berkmortel, F.
    Boers-Sonderen, M.
    de Groot, J. W. B.
    Haanen, J. B. A. G.
    Hospers, G. A. P.
    Kapiteijn, E.
    Piersma, D.
    van Rijn, R.
    Suijkerbuijk, K. P. M.
    ten Tije, A. J.
    Van der Veldt, A. A. M.
    Vreugdenhil, G.
    Wouters, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S745 - S746
  • [42] IMMUNOGENICITY OF A POLYVALENT MELANOMA TUMOR-ANTIGEN VACCINE IN MAN
    BYSTRYN, JC
    LEVIN, M
    BERNSTEIN, P
    SPEYER, J
    WOLSK, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 229 - 229
  • [43] THE ANTIBODY-RESPONSE TO IMMUNIZATION TO A POLYVALENT MELANOMA ANTIGEN VACCINE
    LI, J
    HENN, M
    ORATZ, R
    BYSTRYN, JC
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 94 (04) : 549 - 549
  • [44] PREPARATION AND CHARACTERIZATION OF A POLYVALENT HUMAN-MELANOMA ANTIGEN VACCINE
    BYSTRYN, JC
    JACOBSEN, S
    HARRIS, M
    ROSES, D
    SPEYER, J
    LEVIN, M
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1986, 5 (03): : 211 - 224
  • [45] Long-term survival of a metastatic cerebral melanoma
    Banayan, A
    Vital, C
    NEUROCHIRURGIE, 1998, 44 (04) : 275 - 277
  • [46] THE ANTIBODY-RESPONSE TO IMMUNIZATION TO A POLYVALENT MELANOMA ANTIGEN VACCINE
    LI, J
    HENN, M
    ORATZ, R
    BYSTRYN, JC
    CLINICAL RESEARCH, 1990, 38 (02): : A660 - A660
  • [47] Long-term outcomes of stage IIB-IV melanoma patients: nationwide data from Norway
    Winge-Main, Anna
    Robsahm, Trude E.
    Nyakas, Marta
    Festervoll, Gry
    Torkilseng, Einar
    Thybo, Signe
    Pati, Suvendu
    Carroll, Robert
    FUTURE ONCOLOGY, 2023, 19 (03) : 205 - 215
  • [48] Long-term outcomes of stage IIB-IV melanoma patients: Nationwide data from Norway
    Winge-Main, A.
    Robsahm, T. E.
    Nyakas, M. S.
    Festervoll, G.
    Torkilseng, E.
    Thybo, S.
    Pati, S.
    Carroll, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S766 - S767
  • [49] Randomized, double-blind, clinical trial of a polyvalent melanoma vaccine in patients with stage III melanoma.
    Bystryn, JC
    Oratz, R
    Shapiro, R
    Harris, M
    Roses, D
    Jacquotte, A
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 498 - 498
  • [50] Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine
    Hsueh, EC
    Gupta, RK
    Qi, K
    Morton, DL
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (09) : 2913 - 2920
12345